FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2589278081> ?p ?o ?g. }

• W2589278081 abstract "To evaluate a diagnostic value of transoesophageal echocardiogram (TEE) in appropriately anticoagulated patients with a non-valvular atrial fibrillation (AF) and to establish possible additional indications for TEE; to evaluate the incidence of left atrial (LA) thrombi in appropriately anticoagulated patients in daily clinical practice. This retrospective study analyses data of 432 patients who had been anticoagulated by means of oral anticoagulants (OACs) prior to planned cardioversion during the period from 2012 to 2015. Thromboembolic (TE) and bleeding risks were assessed using CHA2DS2-VASc and HAS-BLED scores. Transthoracic and transoesophageal echocardiograms were evaluated. TE complications during 30 days after discharge were assessed. 432 patients were selected, aged from 22 to 89 years (mean 65.0 ±11.5), 277 (64.1%) males and 155 (35.9%) females, 306 (70.8%) on warfarin and 126 (29.2%) on non-vitamin K antagonist oral anticoagulants (NOAC). Mean CHA2DS2-VASc score was 3.5 ±1.5. TEE was performed for 120 (27.8%) patients, more frequently for patients on NOACs and for ones with III° LA enlargement. TEE revealed LA thrombi in seven (5.8%) of the patients. In warfarin and NOACs groups thrombi were revealed in five (7.0%) and two (4.1%) patients, respectively. TEE did not reveal any thrombi in patients with normal left ventricular (LV) function; however, thrombi were found in two (6.1%) patients with slightly decreased LV function, and in five (17.9%) patients with markedly decreased LV function. In patients with decreased left ventricular ejection fraction (LVEF) thrombi in LA were found more frequently than in patients with normal and slightly decreased LVEF (17.9% vs 2.2%, p=0.008). CHA2DS2-VASc score of all 7 patients was ≥5. None of the patients after cardioversion had TE complications 30 days after discharge. The risk of LA thrombi in patients prepared for scheduled cardioversion in line with the guidelines is low. Higher risk of thrombi was present in patients with decreased LVEF (≤40%), CHA2DS2-VASc ≥5. In order to assess more accurately indications to perform TEE for appropriately anticoagulated patients prior to scheduled cardioversion a study with larger number of patients is required." @default.
• W2589278081 created "2017-03-03" @default.
• W2589278081 creator A5012630925 @default.
• W2589278081 creator A5013141212 @default.
• W2589278081 creator A5020742343 @default.
• W2589278081 creator A5026281859 @default.
• W2589278081 creator A5068913919 @default.
• W2589278081 creator A5081413733 @default.
• W2589278081 date "2017-02-23" @default.
• W2589278081 modified "2023-09-30" @default.
• W2589278081 title "Findings of transoesophageal echocardiogram in appropriately anticoagulated patients with persistent atrial fibrillation prior to planned cardioversion" @default.
• W2589278081 cites W143979248 @default.
• W2589278081 cites W1834574045 @default.
• W2589278081 cites W1927251502 @default.
• W2589278081 cites W1963940525 @default.
• W2589278081 cites W1965524611 @default.
• W2589278081 cites W1986318510 @default.
• W2589278081 cites W2013832146 @default.
• W2589278081 cites W2017922054 @default.
• W2589278081 cites W2020346401 @default.
• W2589278081 cites W2051435404 @default.
• W2589278081 cites W2064428105 @default.
• W2589278081 cites W206978033 @default.
• W2589278081 cites W2091787186 @default.
• W2589278081 cites W2127985968 @default.
• W2589278081 cites W2162586165 @default.
• W2589278081 cites W2167775464 @default.
• W2589278081 cites W2281540926 @default.
• W2589278081 cites W2411139373 @default.
• W2589278081 cites W2427094903 @default.
• W2589278081 cites W2509795914 @default.
• W2589278081 cites W2579362106 @default.
• W2589278081 cites W3004050106 @default.
• W2589278081 cites W4234374651 @default.
• W2589278081 cites W4293860347 @default.
• W2589278081 doi "https://doi.org/10.1186/s12872-017-0503-8" @default.
• W2589278081 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5322653" @default.
• W2589278081 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28228120" @default.
• W2589278081 hasPublicationYear "2017" @default.
• W2589278081 type Work @default.
• W2589278081 sameAs 2589278081 @default.
• W2589278081 citedByCount "13" @default.
• W2589278081 countsByYear W25892780812018 @default.
• W2589278081 countsByYear W25892780812019 @default.
• W2589278081 countsByYear W25892780812020 @default.
• W2589278081 countsByYear W25892780812021 @default.
• W2589278081 countsByYear W25892780812023 @default.
• W2589278081 crossrefType "journal-article" @default.
• W2589278081 hasAuthorship W2589278081A5012630925 @default.
• W2589278081 hasAuthorship W2589278081A5013141212 @default.
• W2589278081 hasAuthorship W2589278081A5020742343 @default.
• W2589278081 hasAuthorship W2589278081A5026281859 @default.
• W2589278081 hasAuthorship W2589278081A5068913919 @default.
• W2589278081 hasAuthorship W2589278081A5081413733 @default.
• W2589278081 hasBestOaLocation W25892780811 @default.
• W2589278081 hasConcept C126322002 @default.
• W2589278081 hasConcept C164705383 @default.
• W2589278081 hasConcept C2776301958 @default.
• W2589278081 hasConcept C2776704044 @default.
• W2589278081 hasConcept C2777289489 @default.
• W2589278081 hasConcept C2777682441 @default.
• W2589278081 hasConcept C2777693794 @default.
• W2589278081 hasConcept C2778198053 @default.
• W2589278081 hasConcept C2778661090 @default.
• W2589278081 hasConcept C2779161974 @default.
• W2589278081 hasConcept C2780638905 @default.
• W2589278081 hasConcept C555175668 @default.
• W2589278081 hasConcept C71924100 @default.
• W2589278081 hasConcept C78085059 @default.
• W2589278081 hasConceptScore W2589278081C126322002 @default.
• W2589278081 hasConceptScore W2589278081C164705383 @default.
• W2589278081 hasConceptScore W2589278081C2776301958 @default.
• W2589278081 hasConceptScore W2589278081C2776704044 @default.
• W2589278081 hasConceptScore W2589278081C2777289489 @default.
• W2589278081 hasConceptScore W2589278081C2777682441 @default.
• W2589278081 hasConceptScore W2589278081C2777693794 @default.
• W2589278081 hasConceptScore W2589278081C2778198053 @default.
• W2589278081 hasConceptScore W2589278081C2778661090 @default.
• W2589278081 hasConceptScore W2589278081C2779161974 @default.
• W2589278081 hasConceptScore W2589278081C2780638905 @default.
• W2589278081 hasConceptScore W2589278081C555175668 @default.
• W2589278081 hasConceptScore W2589278081C71924100 @default.
• W2589278081 hasConceptScore W2589278081C78085059 @default.
• W2589278081 hasIssue "1" @default.
• W2589278081 hasLocation W25892780811 @default.
• W2589278081 hasLocation W25892780812 @default.
• W2589278081 hasLocation W25892780813 @default.
• W2589278081 hasLocation W25892780814 @default.
• W2589278081 hasOpenAccess W2589278081 @default.
• W2589278081 hasPrimaryLocation W25892780811 @default.
• W2589278081 hasRelatedWork W1923415053 @default.
• W2589278081 hasRelatedWork W2063551954 @default.
• W2589278081 hasRelatedWork W206978033 @default.
• W2589278081 hasRelatedWork W2245558837 @default.
• W2589278081 hasRelatedWork W2292941107 @default.
• W2589278081 hasRelatedWork W2589278081 @default.
• W2589278081 hasRelatedWork W2793392713 @default.
• W2589278081 hasRelatedWork W3173880122 @default.
• W2589278081 hasRelatedWork W4319019627 @default.
• W2589278081 hasRelatedWork W1899149475 @default.

• next